Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept
Authors
Keywords
-
Journal
Gastroenterology Research and Practice
Volume 2014, Issue -, Pages 1-13
Publisher
Hindawi Limited
Online
2014-07-22
DOI
10.1155/2014/526178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- VEGFA and tumour angiogenesis
- (2013) L. Claesson-Welsh et al. JOURNAL OF INTERNAL MEDICINE
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
- (2013) Jean-Yves Douillard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of targeted agents in metastatic colorectal cancer
- (2013) Hans Prenen et al. Targeted Oncology
- VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis
- (2013) Clarisse Eveno et al. Cell Adhesion & Migration
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Addition of bevacizumab to first-line chemotherapy in advanced colorectal cancer: a systematic review and meta-analysis, with emphasis on chemotherapy subgroups
- (2012) Ligia Traldi Macedo et al. BMC CANCER
- Phase II Clinical and Pharmacokinetic Study of Aflibercept in Patients with Previously Treated Metastatic Colorectal Cancer
- (2012) P. A. Tang et al. CLINICAL CANCER RESEARCH
- Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
- (2012) Carsten Bokemeyer et al. EUROPEAN JOURNAL OF CANCER
- Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours
- (2012) Eric Van Cutsem et al. EUROPEAN JOURNAL OF CANCER
- Panitumumab: a summary of clinical development in colorectal cancer and future directions
- (2012) Guillem Argiles et al. Future Oncology
- A phase I study of intravenous aflibercept with FOLFIRI in Japanese patients with previously treated metastatic colorectal cancer
- (2012) Takayuki Yoshino et al. INVESTIGATIONAL NEW DRUGS
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
- (2012) Axel Grothey et al. LANCET
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
- (2012) Jaafar Bennouna et al. LANCET ONCOLOGY
- Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer
- (2012) Yellela S. R. Krishnaiah et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
- (2011) J Cassidy et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effect of VEGF and VEGF Trap on vascular endothelial cell signaling in tumors
- (2011) Wiem Lassoued et al. CANCER BIOLOGY & THERAPY
- Macrophage regulation of tumor angiogenesis: Implications for cancer therapy
- (2011) Mario Leonardo Squadrito et al. MOLECULAR ASPECTS OF MEDICINE
- The Inflammatory Microenvironment in Colorectal Neoplasia
- (2011) Mairi H. McLean et al. PLoS One
- Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model
- (2010) Sandra R. Brave et al. ANGIOGENESIS
- Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer
- (2010) Tian-Bao Wang et al. ANZ JOURNAL OF SURGERY
- Vascular endothelial growth factor receptor-1 in human cancer
- (2010) Jonathan D. Schwartz et al. CANCER
- Differential Effects of VEGFR-1 and VEGFR-2 Inhibition on Tumor Metastases Based on Host Organ Environment
- (2010) Y.-J. Lee et al. CANCER RESEARCH
- Aflibercept (VEGF Trap): one more double-edged sword of anti-VEGF therapy for cancer?
- (2010) Ketao Jin et al. Clinical & Translational Oncology
- Tumor Microvasculature and Microenvironment: Novel Insights Through Intravital Imaging in Pre-Clinical Models
- (2010) DAI FUKUMURA et al. MICROCIRCULATION
- Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome
- (2010) Valeria Barresi et al. VIRCHOWS ARCHIV
- Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
- (2009) Alberto Mantovani et al. HUMAN IMMUNOLOGY
- Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
- (2009) Axel Grothey et al. Nature Reviews Clinical Oncology
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Migratory neighbors and distant invaders: tumor-associated niche cells
- (2008) J. Wels et al. GENES & DEVELOPMENT
- Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients
- (2008) Andrew A. Alabi et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started